{{Rsnum
|rsid=1463605
|Chromosome=12
|position=29960950
|Orientation=plus
|GMAF=0.1547
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 83.2 | 15.9 | 0.9
| HCB | 71.5 | 27.7 | 0.7
| JPT | 61.9 | 31.0 | 7.1
| YRI | 55.5 | 39.7 | 4.8
| ASW | 59.6 | 35.1 | 5.3
| CHB | 71.5 | 27.7 | 0.7
| CHD | 70.6 | 27.5 | 1.8
| GIH | 55.0 | 38.0 | 7.0
| LWK | 73.6 | 24.5 | 1.8
| MEX | 82.5 | 17.5 | 0.0
| MKK | 64.1 | 32.7 | 3.2
| TSI | 67.3 | 30.7 | 2.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs1463605
|PubMedID=17903295
|Condition=Aging traits
|Gene=Intergenic
|Risk Allele=
|pValue=7.00E-008
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs1463605
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903295; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study (Initial Sample Size: 1,345 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Aging traits.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356444
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1463605
|overall_frequency_n=24
|overall_frequency_d=128
|overall_frequency=0.1875
|n_genomes=21
|n_genomes_annotated=0
|n_haplomes=24
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}